• / Free eNewsletters & Magazine
  • / My Account
Home>Amgen ends trials of stomach-cancer therapy

Amgen ends trials of stomach-cancer therapy

3party Content

Mon, 24 Nov 2014

By Tess Stynes Amgen Inc. said it ended clinical studies of a treatment for advanced stomach cancer based on safety concerns. The biopharmaceutical company said an independent data-monitoring committee found an increase in the number of deaths in patients using a combination of the experimental
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.